𝔖 Bobbio Scriptorium
✦   LIBER   ✦

First-line chemotherapy for ovarian cancer – the controversy continues

✍ Scribed by Kaye, S B

Book ID
109997380
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
42 KB
Volume
87
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, paclitaxel and cisplatin fir
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
✍ Christos A. Papadimitriou; Charalambos Kouroussis; Lia A. Moulopoulos; Georgios 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## BACKGROUND. The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with th